Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epstein-Barr Virus Reactivation”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableNot Yet RecruitingNCT07703657
What this trial is testing

Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationEpstein-Barr Virus ReactivationClinically Significant EBV DNAemia
Yang Donglin 168
Not applicableStudy completedNCT01744587
What this trial is testing

Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients

Who this might be right for
NPC
National Health Research Institutes, Taiwan 353
Testing effectiveness (Phase 2)Looking for participantsNCT02532452
What this trial is testing

Third Party Viral Specific T-cells (VSTs)

Who this might be right for
Viral InfectionViral ReactivationInfection in an Immunocompromised Host
Children's Hospital Medical Center, Cincinnati 1,000
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138989
What this trial is testing

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 10
Testing effectiveness (Phase 2)Looking for participantsNCT02048332
What this trial is testing

Donor-Derived Viral Specific T-cells (VSTs)

Who this might be right for
Allogeneic Stem Cell TransplantViral InfectionViral Reactivation
Children's Hospital Medical Center, Cincinnati 1,000
Not applicableLooking for participantsNCT07693881
What this trial is testing

Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
EBV Infection After Allogenic HSCT
Nanfang Hospital, Southern Medical University 106
Not applicableNot Yet RecruitingNCT06426758
What this trial is testing

Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

Who this might be right for
Graves DiseaseGraves' Disease in RemissionEpstein-Barr Virus
Xiao-Ming Mao 300
Early research (Phase 1)Looking for participantsNCT05183490
What this trial is testing

R-MVST Cells for Treatment of Viral Infections

Who this might be right for
Epstein-Barr Virus InfectionsCytomegalovirus InfectionsAdenovirus+1 more
Columbia University 36
Very early researchUnknownNCT04690036
What this trial is testing

PD-1 Antibody for Reactive EBV After BMT

Who this might be right for
PD-1EBV InfectionTransplant
Beijing Friendship Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00711035
What this trial is testing

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
Adenovirus InfectionEBV Infection
Baylor College of Medicine 50
Not applicableActive Not RecruitingNCT07536048
What this trial is testing

A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years

Who this might be right for
Epstein-Barr Virus (EBV)Healthy Volunteers
Sanofi Pasteur, a Sanofi Company 100
Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine